Therapeutic Advances in Musculoskeletal Disease
该刊是经过同行评审的开放获取期刊,出版风湿病学、骨质疏松症以及相关学科各领域的前沿探索和创新研究。
该刊2018年影响因子相较2017年增长了46%。
-
-
Ranked 6 out of 31 in Rheumatology
-
Listed in PubMed and indexed in Web of Science, Science Citation Index Expanded (SCIE), Scopus and Directory of Open Access Journals (DOAJ)
-
-
-
Over 500,000 article views on PubMed Central in 2018
期刊主页:
https://journals.sagepub.com/home/taba
Journal of International Medical Research
该刊是经过同行评审的开放获取期刊,重点关注并出版原创的医学研究、临床前与临床研究成果,综述文章及初步和试验研究内容。
该刊
2018年影响因子相较2017年增长32%。
Authors will enjoy:
期刊主页:
https://journals.sagepub.com/home/imra
Therapeutic Advances in Endocrinology and Metabolism
该刊是经过同行评审的开放获取期刊,出版内分泌病学与代谢病学领域的前沿探索和创新研究。
-
-
-
Indexed in PubMed, PubMed Central, Scopus, SCIE
-
-
-
Over 540,000 article views on PubMed Central in 2018
期刊主页:
https://journals.sagepub.com/home/taea
Therapeutic Advances in Gastroenterology
该刊是经过同行评审的开放获取期刊,出版消化病学与肝脏病学领域的前沿探索和创新研究。
-
-
Ranked 25 out of 84 in Gastroenterology & Hepatology
-
Listed in PubMed and indexed in SCIE, Scopus and DOAJ
-
-
-
Over 1 million total article views on PubMed Central in 2018
期刊主页:
https://journals.sagepub.com/home/taga
Therapeutic Advances in Medical Oncology
该刊是经过同行评审的开放获取期刊,出版癌症药物治疗领域的前沿探索和创新研究。
Authors will enjoy:
-
-
Ranked 39 out of 229 in Oncology
-
Listed in PubMed, SCIE, PMC, Scopus and DOAJ
-
International expert Editorial Board and panel of Associate Editors
-
Rigorous and fast peer review
-
Rapid online publication (~3 weeks after article acceptance)
期刊主页:
https://journals.sagepub.com/home/tama
Clinical and Applied Thrombosis/Hemostasis
该刊是经过同行评审的开放获取期刊,出版癌症药物治疗领域的前沿探索和创新研究。
-
Impact Factor:
1.846
-
Rigorous peer review of your research
-
Multidisciplinary audience
-
Open access format, driving high visibility and global exposure
-
Prompt online publication